This medical device stock looks like a gift for patient investors
Insulet is a high-quality compounder where a temporary execution issue is masking strong underlying fundamentals. Type 2 diabetes…
K, C or E? Why economists can’t agree on the shape of today’s economy
C. K. E. Those aren’t initials or Greek life letters. They’re some of the terms that economists, corporate…
We’re booking a 300% profit in an AI winner and buying more of a healthcare name
We are selling 165 shares of Broadcom at roughly $361.27 and buying 50 shares of Cardinal Health at…
Wall Street analysts just called this healthcare stock a buy — here’s our take
Every weekday, the CNBC Investing Club with Jim Cramer holds a “Morning Meeting” livestream at 10:20 a.m. ET.…
Novo Nordisk CEO defends lawsuit against Eli Lilly: ‘Competition has to be fair’
Novo Nordisk CEO Mike Doustdar on Wednesday defended the drugmaker’s decision to sue rival Eli Lilly over its…
Retiring with ₹75 lakh? Experts reveal how much to keep in cash and where to invest the rest
Retirement is a major financial milestone. After decades of earning and building wealth, the focus shifts from accumulating…
How the market may react to July’s CPI report, according to JPMorgan
Stocks could be in for some notable swings on Wednesday after July’s consumer price index reading, according to…
Nvidia, Wall Street asset managers partner on $500B AI push
Nvidia is attempting to turn its artificial intelligence chips into Wall Street’s newest asset class, partnering with six…
Moneymaxxing: Using the viral trend to save, budget, build wealth
ViewApart | iStock | Getty Images As consumers look for ways to strengthen their financial footing, a new…
Shopify exec says AI is ushering in a ‘golden age of entrepreneurship’
Shopify President Harley Finkelstein said Wednesday artificial intelligence is making it easier than ever to start and grow…
Jim Cramer says investors should consider buying SpaceX for their kids
CNBC’s Jim Cramer said Wednesday investors looking at Elon Musk’s SpaceX should stop thinking in quarters and start…
We’re increasing our Eli Lilly price target after another beat-and-raise quarter
Eli Lilly on Wednesday reported better-than-expected quarterly results and raised its full-year guidance as the company’s portfolio of…